Gilotrif

Active Ingredient(s): Afatinib
FDA Approved: * July 12, 2013
Pharm Company: * BOEHRINGER INGELHEIM
Category: Cancer

Afatinib, sold under the brand name Gilotrif among others, is a medication used to treat non-small cell lung carcinoma (NSCLC).[2][3][4] It belongs to the tyrosine kinase inhibitor family of medications.[5] It is taken by mouth.[5][1] It is mainly used to treat cases of NSCLC that harbour mutations in the epidermal growth factor receptor (EGFR) gene.[6] It is on the World Health Org... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Gilotrif 30 mg Oral Tablet

NDC: 0597-0137

Labeler:

Boehringer Ingelheim Pharmaceuticals, Inc.

Gilotrif 40 mg Oral Tablet

NDC: 0597-0138

Labeler:

Boehringer Ingelheim Pharmaceuticals, Inc.

Gilotrif 20 mg Oral Tablet

NDC: 0597-0141

Labeler:

Boehringer Ingelheim Pharmaceuticals, Inc.